Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L14 pseudogene 3 (RPL14P3)
- Target
- RPL14P3
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L14 pseudogene 3 (RPL14P3) is a processed pseudogene derived from the ancestral ribosomal protein L14 gene. It is located in the human genome and shares sequence homology with the functional RPL14 gene. Unlike the protein-coding gene RPL14, RPL14P3 does not encode a functional protein and is generally transcriptionally inactive. Pseudogenes such as RPL14P3 arise from gene duplication or retrotransposition events, and while some pseudogenes may exhibit transcription or regulatory roles, most, including RPL14P3, are not involved in canonical cellular functions and are not considered therapeutic targets.
- Other names
- RPL14_2_522RPL14P3
02
Mechanism of action
None (no known mechanism of action, as it is not an active biological target)
03
Biological functions
None (pseudogenes do not have characterized biological functions as they do not produce active proteins and are usually transcriptionally inactive or non-functional)
04
Disease associations
None specific to RPL14P3; although its parent gene RPL14 is associated with ribosomal function and has disease associations, pseudogenes themselves generally do not play direct roles in disease
05
Safety considerations
None (no therapeutic interventions or safety concerns related to non-functional pseudogenes)
06
Interacting drugs
None (no drugs are known to interact with this pseudogene)
07
Biomarkers
None (not used as a biomarker for patient selection or efficacy monitoring)
Beyond the preview
Go deeper on Ribosomal protein L14 pseudogene 3 (RPL14P3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L14 pseudogene 3 (RPL14P3).